Wealthspire Advisors (New York)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Wealthspire Advisors (New York)'s LLY Position: Q1 2026 in Review
Wealthspire Advisors (New York) increased its Eli Lilly (LLY) stake by 21% in Q1 2026, buying an estimated $2.74M and bringing the position to 15,510 shares worth $14.3M. The position accounts for 0.11% of the portfolio, ranked #91.
Wealthspire Advisors (New York) first reported a position in LLY in Q4 2018 and has held it in 28 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Wealthspire Advisors (New York) held 15,510 shares of Eli Lilly worth $14.3M as of Q1 2026.
- Wealthspire Advisors (New York) bought 2,699 Eli Lilly shares in Q1 2026, an estimated $2.74M.
- Eli Lilly made up 0.11% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #91 holding.
- Wealthspire Advisors (New York) first reported a position in Eli Lilly in Q4 2018 and has held it in 28 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.